Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2.
作者信息
Willis M D, Robertson N P
机构信息
Department of Neurology, University Hospital Wales, Cardiff, CF14 4XN, UK.
Institute of Psychological Medicine and Clinical Neuroscience, Cardiff University, University Hospital of Wales, Heath Park, Cardiff, CF14 4XN, UK.
出版信息
J Neurol. 2020 May;267(5):1567-1569. doi: 10.1007/s00415-020-09822-3.
Abstract
摘要
相似文献
1
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2.多发性硬化症与感染风险：关于新型冠状病毒COVID-19/SARS-CoV-2威胁的考量
J Neurol. 2020 May;267(5):1567-1569. doi: 10.1007/s00415-020-09822-3.
2
Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod.两名接受芬戈莫德治疗的多发性硬化症患者出现无症状的严重急性呼吸综合征冠状病毒2感染。
Mult Scler Relat Disord. 2020 Oct;45:102414. doi: 10.1016/j.msard.2020.102414. Epub 2020 Jul 19.
3
Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis care.冠状病毒病（COVID-19）大流行对多发性硬化症护理的影响。
Clin Neurol Neurosurg. 2020 Oct;197:106203. doi: 10.1016/j.clineuro.2020.106203. Epub 2020 Sep 2.
4
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.一名接受芬戈莫德治疗的多发性硬化症患者感染了新冠病毒。
Neurol Neuroimmunol Neuroinflamm. 2020 May 5;7(4). doi: 10.1212/NXI.0000000000000753. Print 2020 Jul.
5
The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.与 COVID-19 大流行期间多发性硬化症疾病修正治疗相关的基础生物学。
Mult Scler Relat Disord. 2020 Aug;43:102174. doi: 10.1016/j.msard.2020.102174. Epub 2020 May 12.
6
Pangolins Harbor SARS-CoV-2-Related Coronaviruses.穿山甲携带 SARS-CoV-2 相关冠状病毒。
Trends Microbiol. 2020 Jul;28(7):515-517. doi: 10.1016/j.tim.2020.04.001. Epub 2020 Apr 6.
7
Safety Considerations in the Laboratory Testing of Specimens Suspected or Known to Contain the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).对疑似或已知含有严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的标本进行实验室检测时的安全注意事项。
Am J Clin Pathol. 2020 Apr 15;153(5):567-570. doi: 10.1093/ajcp/aqaa047.
8
Patients with MS treated with immunosuppressive agents: Across the COVID-19 spectrum.接受免疫抑制剂治疗的多发性硬化症患者：在整个新冠疫情范围内。
Rev Neurol (Paris). 2020 Jun;176(6):523-525. doi: 10.1016/j.neurol.2020.04.009. Epub 2020 Apr 27.
9
Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).无症状冠状病毒感染：中东呼吸综合征冠状病毒和严重急性呼吸综合征冠状病毒2（新型冠状病毒肺炎）
Travel Med Infect Dis. 2020 May-Jun;35:101608. doi: 10.1016/j.tmaid.2020.101608. Epub 2020 Feb 27.
10
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.B 细胞耗竭疗法可能会影响伊朗 COVID-19 疫情早期多发性硬化症患者急性呼吸道疾病的易感性。
Mult Scler Relat Disord. 2020 Aug;43:102195. doi: 10.1016/j.msard.2020.102195. Epub 2020 May 13.
引用本文的文献
1
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions.COVID-19 的潜在治疗方法：药物再利用和治疗干预。
J Pharmacol Sci. 2023 May;152(1):1-21. doi: 10.1016/j.jphs.2023.02.004. Epub 2023 Feb 15.
2
Comprehensive Investigations Relationship Between Viral Infections and Multiple Sclerosis Pathogenesis.全面研究病毒感染与多发性硬化症发病机制的关系。
Curr Microbiol. 2022 Dec 2;80(1):15. doi: 10.1007/s00284-022-03112-z.
3
Multiple sclerosis patients' response to COVID-19 pandemic and vaccination in Egypt.埃及多发性硬化症患者对新冠疫情及疫苗接种的反应
Egypt J Neurol Psychiatr Neurosurg. 2022;58(1):131. doi: 10.1186/s41983-022-00573-8. Epub 2022 Nov 17.
4
The impact of COVID-19 on patients with neurological disorders and their access to healthcare in Africa: A review of the literature.COVID-19 对非洲神经障碍患者及其获得医疗保健的影响：文献综述。
Brain Behav. 2022 Sep;12(9):e2742. doi: 10.1002/brb3.2742. Epub 2022 Aug 11.
5
The effect of applying the nursing process based on the Theory of Goal Attainment on activities of daily living and quality of life in persons with multiple sclerosis during COVID-19 pandemic: a clinical trial.基于目标达成理论的护理程序对 COVID-19 大流行期间多发性硬化症患者日常生活活动和生活质量的影响：一项临床试验。
Ir J Med Sci. 2023 Jun;192(3):1361-1369. doi: 10.1007/s11845-022-03104-9. Epub 2022 Jul 25.
6
SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19.SARS-CoV-2 感染多发性硬化症患者：与 COVID-19 治疗、辅助疗法和疫苗的相互作用。
J Neurol. 2022 Sep;269(9):4581-4603. doi: 10.1007/s00415-022-11237-1. Epub 2022 Jul 5.
7
Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha.前瞻性药用植物及其植物化学物质保护自身免疫性疾病患者和癌症患者免受新冠疫情影响：特别关注抹茶。
Front Oncol. 2022 May 18;12:837408. doi: 10.3389/fonc.2022.837408. eCollection 2022.
8
Perspectives and experiences with COVID-19 vaccines in people with MS.多发性硬化症患者接种新冠疫苗的观点与经验
Mult Scler J Exp Transl Clin. 2022 Mar 7;8(1):20552173221085242. doi: 10.1177/20552173221085242. eCollection 2022 Jan-Mar.
9
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.Eph 受体、神经纤毛蛋白-1、P2X7 和 CD147 在 COVID-19 相关神经退行性疾病中的作用：炎症小体和 Jak 抑制剂作为有前途的潜在治疗方法。
Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1.
10
Thermal dysregulation in patients with multiple sclerosis during SARS-CoV-2 infection. The potential therapeutic role of exercise.新冠病毒感染期间多发性硬化症患者的体温调节障碍。运动的潜在治疗作用。
Mult Scler Relat Disord. 2022 Mar;59:103557. doi: 10.1016/j.msard.2022.103557. Epub 2022 Jan 24.
Zotero 插件